Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(26 sites)
United States
OPN Healthcare, Inc., Glendale, California University Cancer & Blood Center, Athens, Georgia Baptist Health, Louisville, Kentucky University of Maryland Medical Center, Baltimore, Maryland FirstHealth Cancer Center, Pinehurst, North Carolina The University of Texas- MD Anderson Cancer Center, Houston, Texas China
The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui Cancer Hospital Chinese Academy of Medical Sciences, Beijing, Beijing Municipality Beijing Cancer Hospital, Beijing, Beijing Municipality Peking Union Medical College Hospital, Beijing, Beijing Municipality Beijing Chest Hospital, Beijing, Beijing Municipality The Affiliated Cancer Hospital of Chongqin University, Chongqing, Chongqing Municipality The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Harbin Medical University Cancer Hospital, Harbin, Heilongjiang Henan Cancer Hospital, Zhengzhou, Henan The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Wuhan Union Hospital of China, Wuhan, Hubei Hunan Cancer Hospital, Changsha, Hunan Jiangsu Province Hospital, Nanjing, Jiangsu
Jilin Cancer Hospital, Changchun, Jilin The First Affiliated Hospital of China Medical University, Shengyang, Liaoning Linyi Cancer Hospital, Linyi, Shangdong Shanghai Chest Hospital, Shanghai, Shanghai Municipality Shanghai Pulmonary Hospital, Shanghai, Shanghai Municipality Sichuan Cancer Hospital, Chengdu, Sichuan Zhejiang Cancer Hospital, Hangzhou, Zhejiang